Prevalence of osteoporosis in schizophrenia patients using the osteoporosis self-assessment tool for Asians

References

• Abreu HC, Reiners AA, Azevedo RC, et al. (2015). Incidence and predicting factors of falls of older inpatients. Rev Saúde Pública, 49, 1–8
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health and Welfare. (2014). Estimating the prevalence of osteoporosis. Cat. no. PHE 178. Canberra: AIHW
   Google Scholar
• Boukhris R, Becker KL. (1972). Calcification of the aorta and osteoporosis. JAMA, 219, 1307–11
   PubMed Web of Science ®Google Scholar
• Chan SP, Teo CC, Ng SA, et al. (2006). Validation of various osteoporosis risks in elderly Chinese females in Singapore. Osteoporos Int, 17, 1182–8
   PubMed Web of Science ®Google Scholar
• Chim H, Tan BH, Ang CC, et al. (2002). The prevalence of menopausal symptoms in a community in Singapore. Maturitas, 41, 275–82
   PubMed Web of Science ®Google Scholar
• Cooper C, Campian G, Melton LJ. (1992). Hip fracture in the elderly: A worldwide projection. Osteoporos Int, 2, 285–9
   PubMed Web of Science ®Google Scholar
• Dhanwal DK, Dennison EM, Harvey NC, Cooper C. (2011). Epidemiology of hip fracture: worldwide geographic variation. Indian J Orthop, 45, 15–22
   PubMed Web of Science ®Google Scholar
• Downey PA, Siegel MI. (2006). Bone biology and the clinical implications for osteoporosis. Phys Ther, 86, 77–91
   PubMed Web of Science ®Google Scholar
• Edwards CJ, Hart DJ, Spector TD. (2000). Oral statins and increased bone-mineral density in postmenopausal women. Lancet, 355, 2218–9
   PubMed Web of Science ®Google Scholar
• Exton-Smith AN, Millard PH, Payne PR, Wheeler EF. (1969). Pattern of development and loss of bone with age. Lancet, 2, 1154–7
   PubMed Web of Science ®Google Scholar
• Firooznia H, Golimbu C, Rafii M, et al. (1984). Quantitative computed tomography assessment of spinal trabecular bone: I. Age-related regression in normal men and women. J Comput Tomogr, 8, 91–7
   PubMedGoogle Scholar
• Foo LL, Vijaya K, Sloan RA, Ling A. (2013). Obesity prevention and management: Singapore's experience. Obes Rev, 14 Suppl 2, 106–13
   Google Scholar
• Ghosh M, Majumdar SR. (2014). Antihypertensive medications, bone mineral densities, and bone fractures: A review of old cardiac drugs that provides new insights into osteoporosis. Endocrine, 46, 397–405
   PubMed Web of Science ®Google Scholar
• Guo P, Wang S, Zhu Y, et al. (2012). Prevalence of osteopenia and osteoporosis and factors associated with decreased bone mineral density in elderly inpatients with psychiatric disorders in Huzhou, China. Shanghai Arch Psychiatry, 24, 262–70
   PubMedGoogle Scholar
• Hafner H, van der Heiden W, Behrens S, et al. (1998). Causes and consequences of the gender difference in age at onset of schizophrenia. Schizophr Bull, 24, 99–113
   PubMed Web of Science ®Google Scholar
• Halbreich U, Rojansky N, Palter S, et al. (1995). Decreased bone mineral density in medicated psychiatric patients. Psychosom Med, 57, 485–91
   PubMed Web of Science ®Google Scholar
• Halbreich U, Palter S. (1996). Accelerated osteoporosis in psychiatric patients: Possible pathophysiological processes. Schizophr Bull, 22, 447–54
   PubMed Web of Science ®Google Scholar
• Halbreich U, Kahn LS. (2003). Hyperprolactinemia and schizophrenia: Mechanisms and clinical aspects. J Psychiatr Pract, 9, 344–53
   PubMedGoogle Scholar
• Halbriech U. (2007). Osteoporosis, schizophrenia, and antipsychotics. CNS Drugs, 21, 641–57
   PubMed Web of Science ®Google Scholar
• Henry MJ, Pasco JA, Nicholson GC, Kotowicz MA. (2011). Prevalence of osteoporosis in Australian men and women: Geelong Osteoporosis Study. Med J Aust, 195, 321–2
   PubMed Web of Science ®Google Scholar
• Hummer M, Malik P, Gasser RW, et al. (2005). Osteoporosis in patients with schizophrenia. Am J Psychiatry, 162, 162–7
   PubMed Web of Science ®Google Scholar
• Jadhav SB, Jain GK. (2006). Statins and osteoporosis: New role for old drugs. J Pharm Pharmacol, 58, 3–18
   PubMed Web of Science ®Google Scholar
• Jung DU, Conley RR, Kelly DL, et al. (2006). Prevalence of bone mineral density loss in Korean patients with schizophrenia: A cross-sectional study. J Clin Psychiatry, 67, 1391–6
   PubMed Web of Science ®Google Scholar
• Jung DU, Kelly DL, Oh MK, et al. (2011). Bone mineral density and osteoporosis risk in older patients with schizophrenia. J Clin Psychopharmacol, 31, 406–10
   PubMed Web of Science ®Google Scholar
• Klibanski A, Neer RM, Beitins IZ, et al. (1980). Decreased bone density in hyperprolactinemic women. N Engl J Med, 303, 1511–14
   PubMed Web of Science ®Google Scholar
• Koh LKH, Sedrine B, Torralba TP, et al. (2001). A simple tool to identify Asian women at increased risk for osteoporosis. Osteoporos Int, 12, 699–705
   PubMed Web of Science ®Google Scholar
• Koh LKH. (2002a). Identifying osteoporosis in a cohort of Singapore women using a simple clinical tool. Osteoporos Int, 13, S116
   Web of Science ®Google Scholar
• Koh LKH. (2002b). Identifying osteoporosis in a cohort of Asian men using a simple clinical tool which identifies osteoporosis in Asian women. Osteoporos Int, 13, S120
   Web of Science ®Google Scholar
• Kung AWC, Ho AYY, Ross PD, Reginster JY. (2005). Development of a clinical assessment tool in identifying Asian men with low bone mineral density and comparison of its usefulness of quantitative bone ultrasound. Osteoporos Int, 16, 849–55
   PubMed Web of Science ®Google Scholar
• Lee A YJ, Chua BSY, Howe TS. (2007). One-year outcome of hip fracture patients admitted to a Singapore hospital: Quality of life post-treatment. Singapore Med J, 48, 996–9
   PubMedGoogle Scholar
• Lee J, Seow C, Wong SS, et al. (2013). Annual review clinic: A chronic disease management model of care for schizophrenia and delusional disorder in Singapore. ASEAN J Psychiatr, 14, 90--4
   Google Scholar
• Muench JM, Hamer AM. (2007). Adverse effects of antipsychotic medication. Am Fam Physician, 81, 617–22
   Google Scholar
• NIH Consensus Statement. (2000). Osteoporosis prevention, diagnosis, and therapy. NIH Consens Statement, 17, 1–45
   Google Scholar
• Riggs BL, Melton LJ III. (1995). The worldwide problem of osteoporosis: Insights afforded by epidemiology. Bone, 17, 505S–11S
   PubMed Web of Science ®Google Scholar
• Raisz LG, Rodan GA. (2003). Pathogenesis of osteoporosis. Endocrinol Metab Clin North Am, 32, 15–24
   PubMed Web of Science ®Google Scholar
• Statistics Singapore. (2014). Population Trends. Available from: http://www.singstat.gov.sg/Publications/publications_and_papers/population_and_population_structure/population2014.pdf [last accessed 20 Oct 2014]
   Google Scholar
• Stubbs B, De Hert M, Sepehry AA, et al. (2014). A meta-analysis of prevalence estimates and moderators of low bone mass in people with schizophrenia. Acta Psychiatr Scand, 130, 470–86
   PubMed Web of Science ®Google Scholar
• Subramaniam M, See A, Vaingankar JA, Chong SA. (2014). Cardiovascular toxicity as a result of psychotropic drugs. In: Ramachandran MS, ed. Heart and toxins, Chapter 9. Amsterdam: Elsevier, 275–303
   Google Scholar
• Teng GG, Curtis Jeffrey R, Saag KG. (2008). Mortality and osteoporotic fractures: Is the link causal, and is it modifiable? Clin Exp Rheumatol, 26, S125–37
   PubMed Web of Science ®Google Scholar